Man Group plc Purchases 26,558 Shares of LivaNova PLC (NASDAQ:LIVN)

Man Group plc boosted its holdings in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 5.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 547,781 shares of the company's stock after buying an additional 26,558 shares during the period. Man Group plc owned about 1.01% of LivaNova worth $25,368,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Russell Investments Group Ltd. raised its holdings in shares of LivaNova by 17.1% in the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after buying an additional 219 shares during the last quarter. Sterling Capital Management LLC increased its position in LivaNova by 800.6% in the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock valued at $75,000 after acquiring an additional 1,441 shares in the last quarter. Vestcor Inc acquired a new stake in LivaNova in the 4th quarter valued at about $204,000. Optimize Financial Inc bought a new position in shares of LivaNova in the fourth quarter worth about $208,000. Finally, Corton Capital Inc. bought a new position in shares of LivaNova in the fourth quarter worth about $214,000. Institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. StockNews.com cut shares of LivaNova from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. Barclays dropped their target price on LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Mizuho cut their price target on LivaNova from $70.00 to $60.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 26th. Wolfe Research cut LivaNova from an "outperform" rating to a "peer perform" rating in a report on Wednesday, February 26th. Finally, The Goldman Sachs Group lowered their price objective on LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $59.17.

LivaNova Price Performance

NASDAQ:LIVN opened at $43.82 on Friday. LivaNova PLC has a 52 week low of $32.48 and a 52 week high of $63.57. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The firm's 50-day simple moving average is $38.28 and its 200 day simple moving average is $44.96. The firm has a market cap of $2.39 billion, a price-to-earnings ratio of 104.33 and a beta of 0.84.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.